IP Library Granted Patent US 7,355,045
Granted Patent B2
US 7,355,045 · App. 10/751,387 · Granted Apr 8, 2008

Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,355,045
App. No.
10/751,387
Granted
Apr 8, 2008
Kind
B2
Abstract

In some embodiments, this invention pertains to isotopically enriched N-substituted piperazine acetic acids. In some embodiments, this invention pertains to methods for the preparation of isotopically enriched N-substituted piperazine acetic acids.

Claims (47)

1. An isotopically enriched N-substituted piperazine acetic acid compound of the formula:

or a salt thereof, wherein;

X is O or S;

Y is a straight chain or branched C1-C6 alkyl group or a straight chain or branched C1-C6 alkyl ether group wherein the carbon atoms of the alkyl group or alkyl ether group each independently are optionally substituted with linked deuterium or fluorine atoms;

each Z is independently hydrogen, deuterium, fluorine, chlorine, bromine, iodine, an amino acid side chain, a straight chain or branched C1-C6 alkyl group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently are optionally substituted with linked deuterium or fluorine atoms, a straight chain or branched C1-C6 alkyl ether group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently are optionally substituted with linked deuterium or fluorine atoms or a straight chain or branched C1-C6 alkoxy group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkoxy and aryl groups each independently are optionally substituted with linked deuterium or fluorine atoms.

2. The compound of claim 1 , wherein the N-substituted piperazine acetic acid is isotopically enriched with two or more heavy atom isotopes.

3. The compound of claim 1 , wherein the N-substituted piperazine acetic acid is isotopically enriched with three or more heavy atom isotopes.

4. The compound of claim 1 , wherein the N-substituted piperazine acetic acid is isotopically enriched with four or more heavy atom isotopes.

5. The compound of claim 2 , wherein the heavy atom isotopes are each independently 18 O, 15 N or 13 C, but not deuterium.

6. The compound of claim 1 , wherein each Z is independently hydrogen, fluorine, chlorine, bromine or iodine.

7. The compound of claim 1 , wherein each Z is independently hydrogen, methyl or methoxy.

8. The compound of claim 1 , wherein Y is methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl or tert-butyl.

9. The compound of claim 1 , wherein X is 16 O or 18 O.

10. The compound of claim 1 , wherein each nitrogen atom of the piperazine ring is independently 14 N or 15 N.

11. The compound of claim 1 of the formula:

wherein,

each C* is independently 12 C or 13 C;

X is O or S;

Y is a straight chain or branched C1-C6 alkyl group or a straight chain or branched C1-C6 alkyl ether group wherein the carbon atoms of the alkyl group or alkyl ether group each independently are optionally sustituted with linked deuterium or fluorine atoms;

each Z is independently hydrogen, deuterium, fluorine, chlorine, bromine, iodine, an amino acid side chain, a straight chain or branched C1-C6 alkyl group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently are optionally substituted with linked deuterium or fluorine atoms, a straight chain or branched C1-C6 alkyl ether group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently are optionally substituted with linked deuterium or fluorine atoms or a straight chain or branched C1-C6 alkoxy group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently are optionally substituted with linked deuterium or fluorine atoms.

12. The compound of claim 1 of the formula:

or a salt therof.

13. The compound of claim 12 , wherein the compound is a zwitterion, mono-TFA salt, a mono-HCl salt, a bis-TFA salt or a bis-HCl salt.

14. The compound of claim 12 , wherein each incorporated heavy atom isotope is present in at least 80 percent isotopic purity.

15. The compound of claim 12 , wherein each incorporated heavy atom isotope is present in at least 93 percent isotopic purity.

16. The compound of claim 12 , wherein each incorporated heavy atom isotope is present in at least 96 percent isotopic purity.

17. The compound of claim 1 , wherein the N-substituted piperazine acetic acid is a mono-TFA salt, a mono-HCl salt, a bis-HCl salt or a bis-TFA salt.

18. The compound of claim 1 , wherein each incorporated heavy atom isotope is present in at least 80 percent isotopic purity.

19. The compound of claim 1 , wherein each incorporated heavy atom isotope is present in at least 93 percent isotopic purity.

20. The compound of claim 1 , wherein each incorporated heavy atom isotope is present in at least 96 percent isotopic purity.

21. The compound of claim 12 , wherein the compound is a carboxylate anion.

22. The compound of claim 1 , wherein the compound is a carboxylate anion.

23. An isotopically enriched N-substituted piperazine acetic acid compound of the formula:

or a salt thereof, wherein;

each X is O or S;

Y is a straight chain or branched C1-C6 alkyl group or a straight chain or branched C1-C6 alkyl ether group wherein the carbon atoms of the alkyl group or alkyl ether group each independently are optionally substituted with linked deuterium or fluorine atoms; and

each Z is independently hydrogen, fluorine, chlorine bromine, iodine, an amino acid side chain or a straight chain or branched C1-C6 alkyl group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently are optionally substituted with linked fluorine atoms;

wherein the N-substituted piperazine acetic acid is isotopically enriched with one or more 13 C atoms and/or 15 N atoms.

24. The compound of claim 23 , wherein Y is a straight chain or branched C1-C6 alkyl group and each Z is independently hydrogen, fluorine , chlorine, bromine, iodine, an amino acid side chain or a straight chain or branched C1-C6 alkyl group.

25. An isotopically enriched N-substituted piperazine acetic acid compound of the formula:

or a salt thereof, wherein;

X is O or S;

Y is a straight chain or branched C1-C6 alkyl group or a straight chain or branched C1-C6 alkyl ether group; and

each Z is independently hydrogen, fluorine, chlorine, bromine, iodine, an amino acid side chain or a straight chain or branched C1-C6 alkyl group; and

wherein the N-substituted piperazine acetic acid is isotopically enriched with one or more 13 C atoms, 15 N atoms and/or 18 O atoms.

26. An isotopically enriched N-substituted piperazine acetic acid compound of the formula:

or a salt thereof, wherein the N-substituted piperazine is isotopically enriched with one or more 13 C atoms, 15 N atoms and/or 18 O atoms.

Assignments (12)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0677. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE THE SECURITY INTEREST. Recorded Mar 4, 2016
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 038006/0883 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
RELEASE OF SECURITY INTEREST Recorded Mar 31, 2010
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 024160/0955 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023985/0801 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2010
From: APPLIED BIOSYSTEMS, LLC
To: DH TECHNOLOGIES PTE. LTD.
Reel/Frame 023937/0854 →
MERGER Recorded Feb 26, 2009
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 022320/0024 →
MERGER Recorded Feb 26, 2009
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 022320/0017 →
CHANGE OF NAME Recorded Feb 26, 2009
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 022320/0010 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2004
From: DEY, SUBHAKAR; PAPPIN, DARRYL J.C.; PURKAYASTHA, SUBHASISH; PILLAI, SASI; COULL, JAMES M.
To: APPLERA CORPORATION
Reel/Frame 014507/0414 →